Learn more about our program or schedule a consult.
Of the 75% who report digestive side effects, symptoms extend well beyond the nausea most commonly discussed in coverage of these medications, underscoring why a one-size-fits-all approach falls short and personalized care matters: 32% nausea 26% constipation 25% bloating or gas 21% acid reflux 21% feeling uncomfortably full after eating very little 21% diarrhea 18% abdominal pain 14% loss of appetite to the point of concern 10% vomiting From Trade-Off to Solution These findings land as GLP-1 use accelerates
Allergic reactions: Rare, but possible with any peptide
Perioperative management : According to 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists perioperatively, though individualized risk assessment is recommended, particularly for major gastrointestinal surgery or procedures with high aspiration risk
That level of label transparency is not universal in the current peptide supplement market
Infected amphibian (A6) cells had lower total glutathione levels compared with uninfected controls (Figure 3A)
